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ABSTRACT: Irvingia gabonensis is used traditionally to treat diabetes. The antidiabetic effect of the seed extract 
has been demonstrated in human and animal models. This study was designed to evaluate the long-term anti-
diabetic and anti-hyperlipidaemic effects of aqueous stem bark extract of I. gabonensis in streptozotocin-induced 
diabetic rats. Twenty four Wistar rats in three groups, normal control, diabetic control and I. gabonensis treated 
diabetic rats (TDR) were used for this study. Diabetes was induced in 16 rats by intraperitoneal injection of 
streptozotocin (STZ) at 65mg/kg body weight. Upon confirmation of diabetes, the treated diabetic rats were orally 
(by gavage) given aqueous extract of I. gabonensis bark at 200 mg/kg body weight daily for 24 weeks. Body weight 
was monitored weekly, while fasting blood sugar (FBS) and serum lipid profile (triglycerides, total cholesterol, LDL-
cholesterol and HDL-cholesterol) were assessed at specific intervals for 24 weeks. I. gabonensis significantly 
(P<0.05) reduced the FBS of the treated diabetic rats to normal control levels 2 weeks after the commencement of 
treatment. The reduction of FBS was sustained till the end of the study (24 weeks). Furthermore, at various stages 
of monitoring, the extract reduced the STZ-induced elevation of serum triglycerides, total cholesterol and LDL-
cholesterol, and significantly (p<0.05) increased the STZ-induced decrease in HDL-cholesterol. Our study concludes 
that aqueous stem bark extract of I. gabonensis possess significant long-term anti-diabetic and hypolipidaemic 
effects. These anti-hyperlipidaemic effects as well as the presence of phytochemicals with recognizable anti-oxidant 
effects will be useful in the treatment of diabetic complications. 
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INTRODUCTION 
Diabetes mellitus is recognized as a major healthcare 
problem worldwide. The growing incidence of diabetes in 
sub-Sahara Africa is a major concern as there is no 
concurrent increase in healthcare provision, since the 
disease is still largely considered a Western problem (Motala 
and Ramaiya, 2010). Data gathered from epidemiological 
studies have clearly shown increased incidence, particularly 
in type 2 diabetes, which could be attributed to rising rates of 
obesity, physical inactivity, urbanization and ageing (Levitt, 
2008; Mbanya et al., 2010). The rate of increase in diabetes 
in rural African societies is far less than that seen in urban 
areas (Assah et al., 2011), supporting diet and other lifestyle 
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choices as causative factors. Many people in traditional 
African societies treat diabetes with medicinal plants that are 
thought to have fewer side effects (Akah et al., 2011). 
Hundreds of medicinal plants are available in literature with 
recognizable anti-diabetic effects (Bnouham et al., 2006; 
Neelesh et al., 2010). It is therefore imperative to study these 
plants for efficacy and safety, as well as providing a 
background for developing drugs that have superior 
therapeutic or even curative effects on diabetes. 
Irvingia gabonensis is used widely in Nigeria and other 
African countries as food and medicinal plant (Ekpe et al., 
2007; Awono et al., 2009), it is also used traditionally to treat 
diabetes (Ogunwande et al., 2007). The seed extract has 
been reported to have anti-diabetic effects on human type 2 
diabetes (Adamson et al., 1990) and streptozotocin-induced 
diabetic rats (Ngondi et al., 2006). The aqueous stem bark 
extract has also been demonstrated to have sustained anti-
obesity and hypoglycaemic effects in normal rabbits 
(Omonkhua and Onoagbe, 2012). Since diabetes is a chronic 
disease and most diabetics who use medicinal plant extracts 
to manage diabetes consume these extracts for a long period 
of time, this study was designed to evaluate the long-term (24 
weeks) anti-diabetic and anti-hyperlipidaemic effects of 
aqueous stem bark extract of I. gabonensis in streptozotocin 
diabetic rats.  
 
MATERIALS AND METHODS 
Reagents 
Streptozotocin (Sigma, London), Randox kits for glucose, 
total cholesterol, total triglycerides and HDL-cholesterol 
(product of Randox Laboratory Ltd, Ardmore, Diamond Road, 
Crumlin, Co. Anrtim, United Kingdom) and other analytical 
grade chemicals were used for this study. 
Plant materials 
The bark of I. gabonensis was obtained from the local forest 
at Akungba-Akoko, Ondo State, Nigeria. The identity of the 
plant was authenticated by Dr A. E. Ayodele of the 
Department of Microbiology and Botany, University of Ibadan, 
Ibadan, Nigeria. Herbarium specimen, with voucher number 
UIH 22286 was deposited at the Herbarium of the University 
of Ibadan, Nigeria. 
The plant material was prepared by a modification of the 
method described previously (Onoagbe et al., 1999). Briefly, 
pulverized dry plant material was soaked in distilled water for 
72 hours in a plastic container and covered with cheesecloth. 
The content was stirred several times a day and at the end of 
the third day the content was filtered through two layers of 
cheesecloth.  To ascertain the yield of the extract, 1 ml of the 
homogeneous filtrate was dried by controlled heating (below 
40 oC) in a pre-weighed watch glass to constant weight; this 
was done in triplicates and the average determined. The 
average yield of extract obtained was 32 mg/ml. The extract 
was kept frozen until use, when it was allowed to thaw at 
room temperature. 
Animals 
Twenty-four (24) adult rats of the Wistar strain, with average 
weight of 215.7g obtained from the Animal Unit of the 
University of Ibadan Teaching Hospital (UCH), Ibadan, 
Nigeria, were used for this study. They were kept in a well 
aerated room, with 12h light and 12h dark cycles. They were 
allowed food (standard pelleted feed) and water ad libitum 
and allowed to acclimatize for three weeks before the 
commencement of the study. Treatment of the animals 
conformed to the guidelines in the Principles of Laboratory 
Animal Care (NIH Publication 85-23, revised 1985).  The 
study was reviewed and approved by the Local Institutional 
Review Board.  
Induction of Diabetes 
Rats were injected (i.p.) with streptozotocin dissolved in 
acidified (pH 4.5) normal saline at a dose of 65 mg/kg body 
weight after a 12-hour fast. Seven (7) days later, diabetes 
was confirmed by measuring fasting blood sugar. Rats with 
FBS higher than 8.2 mmol/l and glucosuria were randomly 
distributed into groups 2 and 3. 
Experimental Design 
Three groups of eight rats each were used for this study, 
namely: Group 1: normal control rats given water for 24 
weeks, Group 2: diabetic control rats given water for 24 
weeks and Group 3: I. gabonensis treated diabetic rats 
(TDR), orally given 200 mg/kg body weight of I. gabonensis 




Figure 1: Effect of I. gabonensis on body weight of STZ-induced 
diabetic rats. Data are means of 4-8 determinations ± SEM. Error 
bars were less than 15% of mean values and are omitted for lucidity. 
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Before the administration of STZ, blood was collected from 
the tail vein of each rat to obtain the basal levels of all 
parameters. After the confirmation of diabetes (FBS ≥ 8.2 
mmol/l) and the commencement of treatment with I. 
gabonensis bark extract; FBS was assessed at week 2 and 
then week 4, thereafter, once every four (4) weeks. Other 
parameters were assessed once every 4 weeks. During the 
period of monitoring, blood was collected from the tail vein of 
each rat. At the end of the monitoring phase, the rats were 
sacrificed and blood was obtained through heart puncture. 
Blood for glucose assays was collected in fluoride bottles 
while that for serum lipid profile was collected in plain bottles. 
Blood samples for glucose and biochemical assays were 
allowed to clot on ice and centrifuged at 1,000 X g for 5 
minutes; the serum was then separated for analysis.  
Biochemical Analyses 
Fasting blood glucose was measured by the glucose oxidase 
method of Barham and Trinder (1972), while serum total 
triglyceride concentration was measured by the Tietz (1990) 
method. Serum total cholesterol level and serum HDL-
cholesterol concentration were analyzed by the Richmond 
(1973) and Lopes-Virella et al. (1977) methods respectively. 
Serum LDL-cholesterol level was calculated by the 
Friedewald et al. (1972) method, as described in the manual 
of the Randox HDL-cholesterol kit. 
Statistical analysis 
Data are means of 4-8 determinations ± standard error of 
mean (SEM). The differences among groups were analyzed 
by the one-way analysis of variance (ANOVA). Inter-group 
comparisons were done using Duncanʼs Multiple Range Test 
(DMRT) with 95% confidence intervals.  The SPSS 11.0, 
SPSS Inc., Chicago, Illinois, USA, was used for this analysis. 
 
RESULTS  
The results obtained from this study are displayed in Figures 
1 to 7. Figure 1 shows the effect of streptozotocin (STZ) 
diabetes and its treatment with I. gabonensis on body weight 
of rats. For the duration of this study, comparison between 
groups showed that the body weight gain of the untreated 
STZ-diabetic rats insignificantly reduced compared to normal 
control.  The body weight reduction of the diabetic control 
group was more than that of the treated diabetic group for 
most parts of the study. The body weight increase of the 
treated diabetic rats improved from week 13 (Normal control - 
246.8 ± 19, Diabetic control - 210.8 ± 14.6 and I. gabonensis 
TDR - 227.6 ± 22), a point from which the body weight of the 
I. gabonensis treated diabetic rats (TDR) were similar to that 
of normal control. 
There were no statistically significant differences observed in 
the liver-body weight ratio of all groups of rats (Figure 2). 
However, the relative liver weight of the diabetic control 
group was insignificantly higher than normal control and I. 
gabonensis TDR. The relative kidney weight of the diabetic 
control rats was significantly (p<0.05) higher than normal 
control, while the kidney-body weight of the I. gabonensis 
TDR was significantly lower than the diabetic control group 
but similar to normal control. No statistical difference was 
observed between normal and diabetic control groups in the 
heart-body weight ratio. The relative heart weight of the I. 
gabonensis TDR was significantly (p<0.05) lower than normal 
and diabetic controls. The relative pancreas weight of the 
untreated diabetic rats was significantly higher than normal 
control, the medicinal plant treated rats had values that were 
similar to normal control, and significantly (p<0.05) lower than 
diabetic control.  
	  
Figure 2: Effect of I. gabonensis on organ-body weight ratio of 
STZ-induced diabetic rats. Data are means of 4-8 determinations 
±SEM. Values carrying different letters are statistically different at 
p<0.05. 
Figure 3 shows the effects of I. gabonensis on fasting blood 
glucose levels of STZ-induced diabetic rats. After the 
administration of streptozotocin (Week 0), the FBS of test 
rats increased significantly (p<0.05) compared to normal 
control. Two (2) weeks after medicinal plant treatment, the 
FBS levels of the diabetic control remained high, while that of 
the I. gabonensis TDR reduced to the levels of normal 
control. This reduction was sustained till the end of the study 
(week 24). 
As presented in Figure 4, significantly (p<0.05) higher serum 
total triglyceride levels in the untreated diabetic groups were 
recorded in weeks 8 and 12, with insignificantly higher values 
in week 24 compared to normal control.  At week 8, a 
significantly higher serum triglyceride level was recorded for 
the I. gabonensis TDR compared to normal and diabetic 
controls but the value was significantly lower than that of 
diabetic control at week 12. At weeks 20 and 24, the serum 
triglyceride levels of this group were insignificantly lower than 
the diabetic control group.  
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The serum total cholesterol levels of the untreated diabetic 
rats were significantly (p<0.05) higher than normal control at 
weeks 4, 12 and 20 (Figure 5). The I. gabonensis TDR had 
serum cholesterol concentrations that were slightly higher 
(week 20) and lower (weeks 12 and 16) than diabetic control.  
	  
Figure 3: Effect of I. gabonensis on fasting blood sugar (FBS) of 
STZ-induced diabetic rats. Data are means of 4-8 determinations ± 
SEM. Error bars were less than 15% of mean values and are omitted 




Figure 4: Effect of I. gabonensis on serum total triglycerides 
(mmol/l) of STZ-induced diabetic rats. Data were obtained from 
serum at pre-determined intervals and are means of 4-8 
determinations ± SEM. Error bars were less than 15% of mean 
values and are omitted for lucidity. Values carrying different letters 
are statistically different at p<0.05 
Serum LDL-cholesterol levels of the untreated diabetic rats 
were significantly (p<0.05) higher than normal control in 
weeks 12, 16 and 20 and insignificantly higher for other 
weeks except week 24 (Figure 6). For the I. gabonensis TDR, 
significantly higher values were seen only in week 20 
compared to diabetic control; weeks 4 and 8 (insignificantly), 
and weeks 12 and 16 (significantly) recorded reduced values.  
The serum HDL-cholesterol levels of the diabetic control rats 
were consistently lower than normal control with significant 
values seen in weeks 4 and 16. At week 4, the serum HDL-
cholesterol levels of the treated diabetic rats were 
significantly (p<0.05) higher than normal and diabetic 
controls (Figure 7). At week 16, the HDL-cholesterol levels of 
the I. gabonensis TDR was similar to normal control but 
significantly higher than diabetic control.  
 
	  
Figure 5: Effect of I. gabonensis on serum total cholesterol 
(mmol/l) of STZ-induced diabetic rats. Data were obtained from 
serum at pre-determined intervals and are means of 4-8 
determinations ± SEM. Error bars were less than 15% of mean 
values and are omitted for lucidity. Values carrying different letters 
are statistically different at p<0.05. 
 
DISCUSSION  
Treatment of adult rats with streptozotocin (STZ) produces a 
diabetic state that is characterized by loss of weight, 
polydipsia, polyuria, glucosuria, polyphagia, 
hypoinsulinaemia and hyperglycaemia (Hakim et al., 1997). 
The hyperglycaemia produced by STZ can be sustained for a 
long period of time. Previous reports show that STZ induced 
hyperglycaemia can persist for twenty-four (24) weeks 
(Howarth et al., 2005). This agrees completely with this study 
where the hyperglycaemic state of the untreated STZ-
diabetic rats was sustained for 24 weeks. This study also 
revealed that aqueous bark extract of I. gabonensis possess 
potent anti-diabetic effects, since the FBS levels of the 
treated STZ diabetic rats returned to normal control levels 
two weeks after the commencement of the treatment. This 
anti-diabetic effect was also sustained for the duration of the 
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study (24 weeks). This implies that I. gabonensis possess 
substances that have anti-diabetic effect. Indeed proximate 
and phytochemical analyses have shown that I. gabonensis 
bark contains nutrients (fibre and carbohydrates) and 
phytochemicals (tannins, saponins and anthraquinones) with 
recognizable anti-diabetic effects (Omonkhua and Onoagbe, 
2010). Fibre (Ashutosh and Jha, 2011) and plant 
polysaccharides (Morada et al., 2011) retard the rate of 
absorption of carbohydrates; also polyphenolics, such as 
tannins, saponins and anthraquinone, have been 
demonstrated to have inhibitory effects on carbohydrate 
digestion and glucose absorption in the intestine (Hanhineva 
et al., 2010). These effects can collectively suppress post-
prandial hyperglycaemia, thus ameliorating the effects of 
dietary carbohydrates on glycaemic control and modulating 
the existing hyperglycaemia. Such fibres have also been 
reported for I. gabonensis seed extract (Ngondi et al., 2005).  
Some medicinal plants have been demonstrated to restore β-
cell function in experimental diabetes (Ahmed et al., 2010; 
Kumari et al., 2012). Indeed, studies have shown that plant 
derived polysaccharides and polyphenolics stimulate insulin 
secretion from pancreatic β-cell (Mao et al., 2009; Hanhineva 
et al., 2010). It is therefore possible that the nutrients and 
phytochemicals present in I. gabonensis could ameliorate 
pancreatic cell destruction and/or stimulate insulin secretion 
from the pancreas. These suggested mechanisms of I. 
gabonensis anti-diabetic action i.e. glycaemic control and 
restoration/stimulation of pancreatic cell function, are not 
necessarily mutually exclusive, but may act together to 
establish and sustain its anti-diabetic effect. 
	  
 
Figure 6: Effect of I. gabonensis on serum LDL-cholesterol 
(mmol/l) of STZ-induced diabetic rats. Data were obtained from 
serum at pre-determined intervals and are means of 4-8 
determinations ± SEM. Error bars were less than 15% of mean 
values and are omitted for lucidity. Values carrying different letters 
are statistically different at p<0.05. 
Weight reduction in STZ diabetes is related to weight 
reduction in type 1 diabetes which STZ mimics and is a result 
of the negative caloric effect of diabetes.  Treatment of 
diabetic rats with I. gabonensis countered the weight loss 
caused by STZ diabetes. STZ-diabetes has been shown to 
cause weight reduction in rats (Zafar et al., 2012) and several 
medicinal plants have been shown to improve STZ-diabetes 
weight reducing effect (Singh et al., 2011; Haidari et al., 
2012). It had previously been demonstrated that aqueous 
stem bark extract of I. gabonensis possess anti-obesity effect 
in normal rabbits (Omonkhua and Onoagbe, 2012). This may 
be relevant in the treatment of type 2 diabetes which is more 
prevalent in Africa. Furthermore, several mechanisms have 
been proposed for the anti-diabetic effect of I. gabonensis 
which may play important roles in the management of both 
type 1 and type 2 diabetes. 
 
	  
Figure 7: Effect of I. gabonensis on serum HDL-cholesterol 
(mmol/l) of STZ-induced diabetic rats. Data were obtained from 
serum at pre-determined intervals and are means of 4-8 
determinations ± SEM.  Error bars were less than 15% of mean 
values and are omitted for lucidity. Values carrying different letters 
are statistically different at p<0.05. 
The relative liver, kidney and pancreas weights of untreated 
STZ diabetic rats were brought to normal control levels by 
treatment with I. gabonensis. It can thus be inferred that 
treatment of diabetic rats with I. gabonensis was able to 
alleviate the negative effect of STZ diabetes on the relative 
weights of these tissues. This may be related to the presence 
of several antioxidant phytochemicals in I. gabonensis stem 
bark which may protect the tissues from STZ-induced 
oxidative damage.  
STZ diabetes results in dyslipidaemia i.e. increase in serum 
triglycerides, total cholesterol and LDL-cholesterol as well as 
decrease in HDL-cholesterol. The consistently higher 
triglyceride levels of the diabetic control group compared to 
normal control clearly indicate that STZ diabetes resulted in 
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hyper-triglyceridaemia. At week 8, the serum triglyceride 
concentration of the I. gabonensis TDR was unexpectedly 
significantly (P<0.05) higher than diabetic control. This was 
however the only point where such an increase occurred; 
other values were either significantly (week 12) or 
insignificantly (weeks 16, 20 and 24) lower.  This shows that 
I. gabonensis had a lowering effect on STZ-induced hyper-
triglyceridaemia. Our results also show that STZ diabetes 
caused an almost consistent increase in serum total 
cholesterol and LDL-cholesterol compared to normal control. 
Again treatment with I. gabonensis caused reductions in 
these parameters for most part of the period of monitoring. 
Perhaps the most obvious anti-hyperlipidaemic effects of I. 
gabonensis treatment in this study, was the consistently 
higher serum HDL-cholesterol concentration of the I. 
gabonensis TDR compared to diabetic control. The anti-
hyperlipidaemic effects of many anti-diabetic plants are well 
documented (Singh et al., 2011; Maruthupandian and 
Mohan, 2011; Ramachandran et al., 2012). Indeed, I. 
gabonensis seed extract has been shown to have significant 
anti-hyperlipidaemic effects in STZ diabetic rats (Dzeufiet et 
al., 2009). Adamson et al. (1990) reported that type 2 
diabetics given I. gabonensis seed extract, had significantly 
lower LDL and VLDL-cholesterol and triglycerides levels, 
while HDL-cholesterol concentration was increased. A similar 
trend was observed in this study. Soluble fibres from plants 
have been shown to reduce serum total cholesterol, LDL-
cholesterol and triglycerides (Saeed et al., 2011). In fact it 
has been reported in a study in the US that increasing 
intakes of refined carbohydrates and decreasing intakes of 
fibre paralleled the increasing prevalence of type 2 diabetes 
mellitus (DM) which had risen to near epidemic proportions in 
that country (Gross et al., 2004). Phytochemicals such as 
saponins (Francis et al., 2002; Gupta et al., 2009) have been 
reported to have hypolipidaemic effects. Plant derived 
saponins interact with bile acids to form large mixed micelles 
which have a higher excretion rate, with the consequent 
enhancement of the conversion of cholesterol to bile acids in 
the liver, thus reducing its serum concentration (Francis et 
al., 2002). The presence of these phytochemicals in I. 
gabonensis stem bark, may contribute greatly to the anti-
hyperlipidaemic effects observed in this study. The chronic 
complications of diabetes mellitus, especially cardiovascular 
diseases, are responsible for most of the morbidity and 
mortality of the disease. The long term antidiabetic and 
antihyperlipidaemic effects observed in this study, as well as 
the presence of several antioxidant phytochemicals in I. 
gabonensis bark, could provide a sustainable means of 
treating diabetes and its complications particularly in Africa 
where the availability of drugs is a limiting factor. 
Conclusion 
The availability of orthodox anti-diabetic drugs in sub-Sahara 
Africa remains a major health care challenge. The 
development of drugs from local sources to combat the 
impending diabetes pandemic is a step in the right direction. 
This necessitates the building of a body of knowledge to 
investigate, validate and assess the safety of folkloric anti-
diabetic remedies. The significant long-term anti-diabetic and 
anti-hyperlipidaemic effects of I. gabonensis aqueous stem 
bark extract observed in this study, presents an opportunity 
for further studies to understand and utilize these effects. 
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